Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Two-sample Mendelian randomization combined with GraphBAN reveals druggable prognostic genes and risk stratification in kidney renal clear cell carcinoma

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 14:45
  • Read more about Two-sample Mendelian randomization combined with GraphBAN reveals druggable prognostic genes and risk stratification in kidney renal clear cell carcinoma

Wavelet Decomposition-Based Genomic Analysis of the Human Electrocardiogram

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 14:31
  • Read more about Wavelet Decomposition-Based Genomic Analysis of the Human Electrocardiogram

Expanding the genetic landscape of endometriosis: Integrative -omics analyses implicate key genes and pathways in a multi-ancestry study of over 1,000,000 women

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 14:29
  • Read more about Expanding the genetic landscape of endometriosis: Integrative -omics analyses implicate key genes and pathways in a multi-ancestry study of over 1,000,000 women

PRISMA: A tensor-based framework for deconstructing the genetic architecture of complex diseases, with application to diabetic retinopathy

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 14:28
  • Read more about PRISMA: A tensor-based framework for deconstructing the genetic architecture of complex diseases, with application to diabetic retinopathy

Mapping genetic risk mechanisms for immune-mediated diseases across human dendritic cell differentiation

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 14:26
  • Read more about Mapping genetic risk mechanisms for immune-mediated diseases across human dendritic cell differentiation

Genetically predicted gut bacteria, circulating bacteria-associated metabolites and liver cancer: A Mendelian randomisation study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 13:59
  • Read more about Genetically predicted gut bacteria, circulating bacteria-associated metabolites and liver cancer: A Mendelian randomisation study

Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 13:57
  • Read more about Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study

Association between coffee consumption and the risk of thyroid cancer: A Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 13:57
  • Read more about Association between coffee consumption and the risk of thyroid cancer: A Mendelian randomization study

Gut microbiota may influence Sjögren's syndrome risk through immune cell mediation: A Mendelian randomization analysis

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 13:54
  • Read more about Gut microbiota may influence Sjögren's syndrome risk through immune cell mediation: A Mendelian randomization analysis

The causal role of plasma metabolites in breast cancer susceptibility mediated by immune cells: A two-sample Mendelian randomization analysis

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 06/01/2026 - 13:41
  • Read more about The causal role of plasma metabolites in breast cancer susceptibility mediated by immune cells: A two-sample Mendelian randomization analysis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Current page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement